Asahi Kasei (3407.T)
Industrials · Tokyo · Japan
Fundamentals
Valuation and ratings
Asahi Kasei trades at ¥1,837.00, close to the ¥1,836.43 our discounted cash flow model puts on the business. On this measure the market and the model broadly agree, so the interesting question is which of them is wrong.
Our moat model scores it 47 out of 100, which is a moat, but not a deep one. A moat is a structural reason competitors cannot take the profits away, and it matters more to a long holding period than any single quarter's numbers do.
It changes hands at 15.7 times earnings. Be careful reading that in isolation: for a cyclical business a low P/E arrives at the top of the cycle, when profits are peaking and about to fall, which is exactly when the shares look cheapest and are not.
About Asahi Kasei
Asahi Kasei Corporation engages in material, homes, and healthcare businesses in Japan, the United States, China, and internationally. The company offers Pimel, a photosensitive PI material applied for semiconductor applications, such as buffer coating, passivation layers, and dielectric layers; Sunfort, a dry film photoresist; Novacure, a latent curing agent for epoxy resin; glass fabric for printed circuit boards; plastic optical fiber; sensors and devices; artificial suede products under the Dinamica name; Microza UF and MF industrial membranes and systems; Aciplex membranes, process equipment, and systems for caustic soda production; alkaline water electrolyzer for producing hydrogen from renewable energy Aqualyzer; Hipore, a microporous polyolefin sheet which prevents the anode and cathode; Celgard, a lithium-ion battery separator; photopolymers and platemaking systems; and fiber products under the Bemberg, Bemliese, NanoAct, and ROICA names. It also provides cling film, bags, and containers under the Saran Wrap, Ziploc, and Cookper names; packaging products under the Suntec, Barrialon, PVDC latex, and Saran fiber names; pharmaceutical and food additives under the Ceolous and Celphere names; and clads and anchors under the Baclad and AR Chemical Setter names. In addition, the company offers prescription drugs in the fields of orthopedics, critical/intensive care, urology, immune system, and central nervous system; virus removal filters; wearable defibrillators, temperature management systems, pre-hospital, and hospital data management systems; overseas homes, unit homes and apartment buildings, and real estate-related operations; autoclaved aerated concretes, foundation systems, thermal insulations, and structural systems and component products; polymers, monomers, foamed products, and cleaners; and synthetic rubber, elastomers, and intermediates and inorganic chemicals. Asahi Kasei Corporation was founded in 1922 and is headquartered in Chiyoda, Japan.
3407.T passes 5 of our 30 screens today
Each screen prints the exact criteria it used, and the circumstances in which it is wrong.
Common questions
Is Asahi Kasei (3407.T) undervalued?
Against our discounted cash flow estimate of ¥1,836.43, 3407.T at ¥1,837.00 is 0% above fair value. That is one model's answer, not a recommendation, and most of a DCF's output sits in a terminal value nobody can forecast.
What is 3407.T's P/E ratio?
3407.T trades at 15.7 times earnings. A low P/E is not automatically cheap: on a cyclical company it is usually a warning that earnings are at a peak.
The full research page for 3407.T, with financial statements, ownership detail, peer comparison and alerts, is free inside the app.
Data from company filings, exchange quotes and SEC EDGAR 13F disclosures. Quotes are delayed. Metrics we do not have are left out rather than estimated. Educational information, not financial advice.